Study Design and Interim Outcomes of Guangzhou Institute of Respiratory Disease COPD Biobank

No abstract is available for this paper.

• Publication year

  2016

• Venue

  COPD

• Publication date

  2016-03-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/15412555.2015.1069807PMID 26625179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Year in review 2013: Chronic obstructive pulmonary disease, asthma and airway biology

  2014cited by this paper
• Grading the severity of airways obstruction: new wine in new bottles

  2013cited by this paper
• Genetic Variants in MUC4 Gene Are Associated with Lung Cancer Risk in a Chinese Population

  2013cited by this paper
• Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations

  2012cited by this paper
• The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study.

  2011cited by this paper
• Genetic Epidemiology of COPD (COPDGene) Study Design

  2011cited by this paper
• Characterisation of COPD heterogeneity in the ECLIPSE cohort

  2010cited by this paper
• COPD as a disease of accelerated lung aging.

  2009cited by this paper
• A Genome-Wide Association Study of Pulmonary Function Measures in the Framingham Heart Study

  2009cited by this paper
• A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci

  2009cited by this paper
• COPD as a disease of accelerated lung aging(a).

  2009cited by this paper
• Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation

  2008cited by this paper
• Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD

  2008cited by this paper
• Definition, epidemiology and natural history of COPD

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Chronic Obstructive Pulmonary Disease: A Chronic Systemic Inflammatory Disease

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Inflammation markers predicting frailty and mortality in the elderly.

  2006cited by this paper
• COPD, a multicomponent disease: implications for management.

  2005cited by this paper
• Standardisation of spirometry

  2005cited by this paper
• Patterns of comorbidities in newly diagnosed COPD and asthma in primary care.

  2005cited by this paper
• Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.

  2000cited by this paper
• The heterogeneity of chronic obstructive pulmonary disease

  2000cited by this paper
• Epidemiology Standardization Project (American Thoracic Society).

  1978cited by this paper

• AutoCOPD–A novel and practical machine learning model for COPD detection using whole-lung inspiratory quantitative CT measurements: a retrospective, multicenter study

  2025cites this paper
• Prevalence of non-smoking chronic obstructive pulmonary disease and its risk factors in China: a systematic review and meta-analysis

  2024cites this paper
• Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD

  2023cites this paper
• Gene Expression Trajectories from Normal Nonsmokers to COPD Smokers and Disease Progression Discriminant Modeling in Response to Cigarette Smoking

  2022cites this paper
• Proteomic profiling reveals a distinctive molecular signature for critically ill COVID-19 patients compared with asthma and chronic obstructive pulmonary disease

  2022cites this paper
• Proteomic profiling reveals a distinctive molecular signature for critically ill COVID-19 patients compared with asthma and chronic obstructive pulmonary disease

  2022cites this paper
• Identification of genetic variants of the IL‐22 gene in association with an altered risk of COPD susceptibility

  2022cites this paper
• A protective polymorphism in MMP16, improved blood gas levels, and chronic obstructive pulmonary diseases: Family and two population‐based studies

  2020cites this paper
• Impacts of event-specific air quality improvements on total hospital admissions and reduced systemic inflammation in COPD patients

  2019cites this paper
• The effects of CXCL10 polymorphisms on COPD susceptibility

  2018cites this paper
• Genetic Variants in the Hedgehog Interacting Protein Gene Are Associated with the FEV1/FVC Ratio in Southern Han Chinese Subjects with Chronic Obstructive Pulmonary Disease

  2017cites this paper